Harriet S. Tenenhouse

Affiliations: 
McGill University, Montreal, QC, Canada 
Area:
Genetics, Molecular Biology
Google:
"Harriet Tenenhouse"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Scriver CR, Tenenhouse HS. (2011) Mendelian Phenotypes as “Probes” of Renal Transport Systems for Amino Acids and Phosphate Comprehensive Physiology. 1977-2016
Iwaki T, Sandoval-Cooper MJ, Tenenhouse HS, et al. (2008) A missense mutation in the sodium phosphate co-transporter Slc34a1 impairs phosphate homeostasis. Journal of the American Society of Nephrology : Jasn. 19: 1753-62
Nowik M, Picard N, Stange G, et al. (2008) Renal phosphaturia during metabolic acidosis revisited: molecular mechanisms for decreased renal phosphate reabsorption. Pflã¼Gers Archiv : European Journal of Physiology. 457: 539-49
Perwad F, Zhang MY, Tenenhouse HS, et al. (2007) Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro. American Journal of Physiology. Renal Physiology. 293: F1577-83
Tenenhouse HS. (2007) Phosphate transport: molecular basis, regulation and pathophysiology. The Journal of Steroid Biochemistry and Molecular Biology. 103: 572-7
Bergwitz C, Roslin NM, Tieder M, et al. (2006) SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis. American Journal of Human Genetics. 78: 179-92
Perwad F, Azam N, Zhang MY, et al. (2005) Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice. Endocrinology. 146: 5358-64
Tenenhouse HS. (2005) Regulation of phosphorus homeostasis by the type iia na/phosphate cotransporter. Annual Review of Nutrition. 25: 197-214
Larsson T, Marsell R, Schipani E, et al. (2004) Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. Endocrinology. 145: 3087-94
Qiu ZQ, Travers R, Rauch F, et al. (2004) Effect of gene dose and parental origin on bone histomorphometry in X-linked Hyp mice Bone. 34: 134-139
See more...